Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Medicare Part B
Regulatory
CMMI proposes new models to lower drug prices in Parts B, D
CMS' Innovation Center has released two new drug pricing models that base rebates on international drug prices, which are significantly lower.
Emma Beavins
Dec 22, 2025 12:00pm
CMS: Medicare Part B premiums set to rise in 2026
Nov 16, 2025 5:00pm
CMMI eyes weight loss drug coverage as IVF pledge slips: reports
Aug 4, 2025 2:50pm
CMS may add Part B drugs to negotiations under draft guidance
May 12, 2025 5:36pm
Payer Roundup—Aetna gets warning; Humana collabs with Thyme Care
Mar 3, 2025 11:34am
HHS releases cost savings for 64 prescription drugs
Dec 20, 2024 11:00am
